Initiation of Vancomycin Therapy and the First Therapeutic Drug Monitoring

Aljefri, D. M., Avedissian, S. N., Rhodes, N. J., Postelnick, M. J., Nguyen, K., Scheetz, M. H. (2019). Vancomycin area under the curve and acute kidney injury: A meta-analysis. Clin. Infect. Diseas.,69 (11), 1881–1888.10.1093/cid/ciz051685368330715208Search in Google Scholar

Álvarez, R., Cortes, L. E. L., Molina, J., Cisneros, J. M., Pachón, J. (2016). Optimizing the clinical use of vancomycin. Antimicrob. Agents Chemother.,60 (5), 2601–2609.10.1128/AAC.03147-14486247026856841Search in Google Scholar

Bakke, V., Sporsem, H., Lippe, E., Nord¸y, I., Lao, Y., Nyrer¸d, H. C., Sandvik, L., Hårvig, K. R. (2017). Vancomycin levels are frequently subtherapeutic in critically ill patients: A prospective observational study. Acta Anaesthesiol. Scand., 61 (6), 627–635.10.1111/aas.12897548505428444760Search in Google Scholar

Baptista, J. P., Sousa, E., Martins, P. J., Pimentel, J. M. (2012). Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int. J. Antimicrob. Agents, 39 (5), 420–423.10.1016/j.ijantimicag.2011.12.01122386742Search in Google Scholar

Barber, K. E., Bell, A. M., Stover, K. R., Wagner, J. L. (2016). Intravenous vancomycin dosing in the elderly: A focus on clinical issues and practical application. Drugs and Aging, 33 (12), 845–854.10.1007/s40266-016-0420-z512261827878526Search in Google Scholar

Bauer, L. A. (2008). Applied Clinical Pharmacokinetics. 2^nd ed. The McGraw-Hill Companies, Inc. 826 pp.Search in Google Scholar

Campassi, M. L., Gonzalez, M. C., Masevicius, F. D., Vazquez, A. R., Moseinco, M., Navarro, N. C., Previgliano, L., Rubatto, N. P., Benites, M. H., Estenssoro, E., Dubin, A. (2014). Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment. Revista Brasileira de Terapia Intensiva, 26 (1), 13–20 (in Portuguese).10.5935/0103-507X.20140003403188624770684Search in Google Scholar

Dolton, M., Xu, H., Cheong, E., Maitz, P., Kennedy, P., Gottlieb, T., Buono, E., McLachlan, A. J. (2010). Vancomycin pharmacokinetics in patients with severe burn injuries. Burns, 36 (4), 469–476.10.1016/j.burns.2009.08.01019875238Search in Google Scholar

Estes, K. S., Derendorf, H. (2010). Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin. Eur. J. Med. Res.,15 (12), 533.10.1186/2047-783X-15-12-533335210221163728Search in Google Scholar

Gould, F. K., Denning, D. W., Elliott, T. S., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., Watkin, R. W., Working Party of the British Society for Antimicrobial Chemotherapy (2012). Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the Working Party of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother.,67 (2), 269–289.10.1093/jac/dkr45022086858Search in Google Scholar

Grace, E. (2012). Altered vancomycin pharmacokinetics in obese and morbidly obese patients: What we have learned over the past 30 years. J. Antimicrob. Chemother.,67 (6), 1305–1310.10.1093/jac/dks06622382471Search in Google Scholar

Hammond, D. A., Atkinson, L. N., James, T. B., Painter, J. T., Lusardi, K. (2017). Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients. Pharmacy Practice, 15 (2), 1–5.10.18549/PharmPract.2017.02.949549935528690700Search in Google Scholar

Hanberger, R. H. (2017). SEPSIS in Emergency & ICU. 3 rev. ed. LiU-Tryck, Universitetet i Linköping, Linköping. 166 pp. (in Swedish).Search in Google Scholar

Hao, J. J., Chen, H., Zhou, J. X. (2016). Continuous versus intermittent infusion of vancomycin in adult patients: A systematic review and meta-analysis. Int. J. Antimicrob. Agents, 47 (1), 28–35.10.1016/j.ijantimicag.2015.10.01926655032Search in Google Scholar

Holmes, N. E. (2020). Using AUC/MIC to guide vancomycin dosing: Ready for prime time? Clin. Microbiol. Infect.,26 (4), 406–408.10.1016/j.cmi.2019.12.02331927116Search in Google Scholar

Jeffres, M. N. (2017).The whole price of vancomycin: Toxicities, troughs, and time. Drugs, 77 (11), 1143–1154.10.1007/s40265-017-0764-7550189928573434Search in Google Scholar

Kane, S. P., Hanes, S. D. (2017). Unexplained increases in serum vancomycin concentration in a morbidly obese patient. Intens. Crit. Care Nursing, 39, 55–58.10.1016/j.iccn.2016.08.00427899248Search in Google Scholar

De Gatta Garcia, M. Del Mar F., M., Revilla, N., Calvo, M. V., Dominguez-Gil, A., Navarro, A. S. (2007). Pharmacokinetic/pharmaco-dynamic analysis of vancomycin in ICU patients. Intens. Care Med.,33 (2), 279–285.Search in Google Scholar

Marquis, K. A., DeGrado, J. R., Labonville, S., Kubiak, D. W., Szumita, P. M. (2015). Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center. Ann. Pharmacother.,49 (9), 1009–1014.10.1177/106002801558790025991831Search in Google Scholar

Martin, J. (2010). TDM for vancomycin-induced nephrotoxicity definition: A minimum of two or three consecutive. Clin. Biochem. Rev., 22, 21–24.Search in Google Scholar

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke E. R., Garey, K. W., Gould, C. V., Kelly, C., Loo, V., Sammons, J. S., Sandora, T. J., Wilcox, M. H. (2018). Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis.,66 (7), e1–e48.10.1093/cid/ciy149Search in Google Scholar

Morbitzer, K. A., Jordan, J. D., Sullivan, K. A., Durr, E. A., Olm-Shipman, C. M., Rhoney, D. H. (2016). Vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke. Neurocrit. Care, 25 (2), 250–257.10.1007/s12028-016-0264-826942732Search in Google Scholar

Morrison, A. P., Morrison, A. P., Melanson, S. E. F., Carty, M. G., Bates, D. W., Szumita, P. M., Tanasijevic, M. J. (2018). What proportion of vancomycin trough Levels are drawn too early? Frequency and impact on clinical actions. Amer. J. Clin. Pathol.,137 (3), 472–478.Search in Google Scholar

Raverdy, V., Ampe, E., Hecq, J.-D., Tulkens, P. M. (2013). Stability and compatibility of vancomycin for administration by continuous infusion. J. Antimicrob. Chemother.,68 (5), 1179–1182.10.1093/jac/dks51023302579Search in Google Scholar

Revilla, N., Martín-Suárez, A., Pérez, M. P., González, F. M., Fernández de Gatta, M. (2010). Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Brit. J. Clin. Pharmacol.,70 (2), 201–212.10.1111/j.1365-2125.2010.03679.x291155020653673Search in Google Scholar

Rybak, M., Lomestro, B., Rotschafer, J. C., Moellerinmg, Jr., R., Craig, W., Billeter, M., Dalovisio, J. R., Levine, D. P. (2009). Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Amer. J. Health-System Pharm.,66 (1), 82–98.10.2146/ajhp08043419106348Search in Google Scholar

Rybak, M. J. (2006). The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin. Infect. Dis., 42 (Suppl. 1), S35–S39.10.1086/49171216323118Search in Google Scholar

Rybak, M. J., Le, J., Lodise, T. P., Levine, D. P., Bradley, J. S., Liu, C., Mueller, B. A., Pai, M. P., Wong-Beringer, A., Rotschafer, J. C., Rodvold, K. A., Maples, H. D., Lomaestro, B. M. (2020).Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Amer. J. Health-System Pharm.,77 (11), 835–863.10.1093/ajhp/zxaa03632191793Search in Google Scholar

Sokolova, V., Sabelnikovs, O. (2013). Effect of vancomycin administration method on achieving and maintaining its serum concentrations in intensive care patients. Acta Chirurgica Latviensis, 13 (1), 18–21.10.2478/chilat-2014-0004Search in Google Scholar

Tabah, A., Waele, J. de, Lipman, J., Zahar, J. R., Cotta, M. O., Barton, G., Timsit, J.-F., Roberts, J. A., Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM) (2015). The ADMIN-ICU survey: A survey on antimicrobial dosing and monitoring in ICUs. J. Antimicrob. Chemother.,70 (9), 2671–2677.10.1093/jac/dkv16526169558Search in Google Scholar

Tafelski, S., Nachtigall, I., Troeger, U., Deja, M., Krannich, A., Günzel, K., Spies, C., ABx Study Group (2015) Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application. J. Infect. Publ. Health, 8 (4), 355–363.10.1016/j.jiph.2015.01.01125794497Search in Google Scholar

Tong, S. Y. C., Lye, D. C., Yahav, D., Sud, A., Robinson, J. O., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D. L. et al. (2020). Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: A randomized clinical trial. J. Amer. Med. Assoc.,323 (6), 527–537.10.1001/jama.2020.0103704288732044943Search in Google Scholar

Traugott, K. A., Maxwell, P. R., Green, K., Frei, C., Lewis, J. S. 2^nd (2011). Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Amer. J. Health-System Pharm.,68 (4), 347–352.10.2146/ajhp09066121289330Search in Google Scholar

Zamoner, W., Prado, I. R. S., Balbi, A. L., Ponce, D. (2019). Vancomycin dosing, monitoring and toxicity: Critical review of the clinical practice. Clin. Exper. Pharmacol. Physiol.,46 (4), 292–301.10.1111/1440-1681.1306630623980Search in Google Scholar